Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chaiqin pediatric antipyretic suppository
- Development stage
- Unknown
- Lead developer
- Anhui Institute of Pharmaceutical Research
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Rectal
01
Overview
Chaiqin pediatric antipyretic suppository is a Traditional Chinese Medicine (TCM) formulation developed for the treatment of fever in children, particularly those suffering from acute upper respiratory infections characterized by the "wind-heat" pattern. The drug is developed by the Anhui Institute of Pharmaceutical Research. Its primary active components are derived from *Radix Bupleuri* (Chaihu) and *Radix Scutellariae* (Huangqin), which are traditionally used in TCM for their antipyretic, anti-inflammatory, and detoxifying properties. Administered rectally as a suppository, it offers a non-oral delivery route suitable for pediatric patients who may experience difficulty with oral medications during illness.
- Other names
- Chaiqin Xiaoer Tuire ShuanChaiqin pediatric antipyretic suppository
02
Targets
PI3K (Phosphoinositide-3-kinase regulatory subunit 6)TLR4 (Toll-like receptor 4)GRIN2B (N-methyl-D-aspartate Receptor Subunit Combination: NR1a/NR2B)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)MYD88 (Myeloid differentiation primary response protein MyD88)
Beyond the preview
Go deeper on chaiqin pediatric antipyretic suppository.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chaiqin pediatric antipyretic suppository.